Senti Biosciences (SNTI) Competitors $3.22 +0.02 (+0.63%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.18 -0.04 (-1.24%) As of 05/21/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNTI vs. CDTX, CYRX, ARCT, OLMA, ITOS, PHAT, TRDA, CGC, IMMP, and AURAShould you be buying Senti Biosciences stock or one of its competitors? The main competitors of Senti Biosciences include Cidara Therapeutics (CDTX), Cryoport (CYRX), Arcturus Therapeutics (ARCT), Olema Pharmaceuticals (OLMA), iTeos Therapeutics (ITOS), Phathom Pharmaceuticals (PHAT), Entrada Therapeutics (TRDA), Canopy Growth (CGC), Immutep (IMMP), and Aura Biosciences (AURA). These companies are all part of the "pharmaceutical products" industry. Senti Biosciences vs. Cidara Therapeutics Cryoport Arcturus Therapeutics Olema Pharmaceuticals iTeos Therapeutics Phathom Pharmaceuticals Entrada Therapeutics Canopy Growth Immutep Aura Biosciences Senti Biosciences (NASDAQ:SNTI) and Cidara Therapeutics (NASDAQ:CDTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, community ranking, risk, valuation and dividends. Do analysts rate SNTI or CDTX? Senti Biosciences presently has a consensus target price of $12.00, suggesting a potential upside of 272.67%. Cidara Therapeutics has a consensus target price of $41.71, suggesting a potential upside of 58.91%. Given Senti Biosciences' higher probable upside, equities research analysts plainly believe Senti Biosciences is more favorable than Cidara Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cidara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Does the media refer more to SNTI or CDTX? In the previous week, Senti Biosciences and Senti Biosciences both had 3 articles in the media. Cidara Therapeutics' average media sentiment score of 0.84 beat Senti Biosciences' score of 0.00 indicating that Cidara Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senti Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cidara Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in SNTI or CDTX? Cidara Therapeutics received 455 more outperform votes than Senti Biosciences when rated by MarketBeat users. Likewise, 70.34% of users gave Cidara Therapeutics an outperform vote while only 45.45% of users gave Senti Biosciences an outperform vote. CompanyUnderperformOutperformSenti BiosciencesOutperform Votes545.45% Underperform Votes654.55% Cidara TherapeuticsOutperform Votes46070.34% Underperform Votes19429.66% Do institutionals and insiders believe in SNTI or CDTX? 25.7% of Senti Biosciences shares are held by institutional investors. Comparatively, 35.8% of Cidara Therapeutics shares are held by institutional investors. 3.1% of Senti Biosciences shares are held by company insiders. Comparatively, 3.9% of Cidara Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is SNTI or CDTX more profitable? Senti Biosciences has a net margin of 0.00% compared to Cidara Therapeutics' net margin of -289.05%. Cidara Therapeutics' return on equity of -69.64% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Senti BiosciencesN/A -154.84% -77.42% Cidara Therapeutics -289.05%-69.64%-33.73% Which has stronger earnings & valuation, SNTI or CDTX? Cidara Therapeutics has lower revenue, but higher earnings than Senti Biosciences. Cidara Therapeutics is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenti Biosciences$2.56M32.81-$71.06M-$10.84-0.30Cidara Therapeutics$302K1,090.59-$22.93M-$29.47-0.89 Which has more volatility & risk, SNTI or CDTX? Senti Biosciences has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500. Comparatively, Cidara Therapeutics has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. SummaryCidara Therapeutics beats Senti Biosciences on 12 of the 18 factors compared between the two stocks. Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNTI vs. The Competition Export to ExcelMetricSenti BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$83.98M$2.92B$5.36B$8.39BDividend YieldN/A1.72%5.22%4.10%P/E Ratio-0.2130.5126.5919.72Price / Sales32.81400.93391.61116.20Price / CashN/A168.6838.2534.62Price / Book0.213.286.794.51Net Income-$71.06M-$72.17M$3.23B$248.18M7 Day Performance0.31%4.32%4.03%1.14%1 Month Performance-18.89%7.68%12.22%15.07%1 Year Performance-14.72%-28.08%16.76%6.59% Senti Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNTISenti Biosciences1.6894 of 5 stars$3.22+0.6%$12.00+272.7%-14.7%$83.98M$2.56M-0.214CDTXCidara Therapeutics4.4689 of 5 stars$26.49+3.9%$41.71+57.5%+147.2%$332.37M$302,000.00-1.0490High Trading VolumeCYRXCryoport3.0008 of 5 stars$6.58-1.5%$11.00+67.2%-48.4%$329.90M$232.13M-1.951,020Positive NewsARCTArcturus Therapeutics2.9267 of 5 stars$11.99+2.9%$57.80+382.1%-59.3%$325.18M$131.27M-5.40180OLMAOlema Pharmaceuticals2.2652 of 5 stars$4.80+1.9%$24.50+410.4%-46.5%$322.26MN/A-2.1970ITOSiTeos Therapeutics2.9745 of 5 stars$8.41+7.7%$17.86+112.3%-54.4%$321.88M$35M-2.6790Positive NewsAnalyst RevisionGap UpHigh Trading VolumePHATPhathom Pharmaceuticals3.8778 of 5 stars$4.39+7.3%$17.60+300.9%-63.7%$306.48M$81.86M-0.77110Positive NewsGap DownTRDAEntrada Therapeutics2.947 of 5 stars$8.01-1.0%$25.67+220.4%-51.0%$304.00M$172.22M5.04110News CoverageAnalyst ForecastAnalyst RevisionCGCCanopy Growth1.4008 of 5 stars$1.64-1.2%$2.00+22.0%-82.2%$301.54M$276.75M-0.433,150Trending NewsIMMPImmutep1.4058 of 5 stars$2.04+0.5%$7.00+243.1%-39.9%$297.92M$5.14M0.002,021Gap DownAURAAura Biosciences2.4542 of 5 stars$5.92-0.5%$22.75+284.3%-14.2%$297.33MN/A-3.4250Earnings ReportInsider TradeGap Up Related Companies and Tools Related Companies Cidara Therapeutics Alternatives Cryoport Alternatives Arcturus Therapeutics Alternatives Olema Pharmaceuticals Alternatives iTeos Therapeutics Alternatives Phathom Pharmaceuticals Alternatives Entrada Therapeutics Alternatives Canopy Growth Alternatives Immutep Alternatives Aura Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNTI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNTI Stock Free SNTI Stock Alerts